This site is intended for healthcare professionals
Multiple Sclerosis (MS) Learning Zone
Declaration of sponsorship Novartis Pharma AG

Congress

Declaration of sponsorship Novartis Pharma AG
Read time: 125 mins
Last updated:12th Aug 2021
Published:12th Aug 2021

Novartis is engaged in Multiple Sclerosis (MS) education and MS care – analyse expert presentation insights in Novartis-sponsored congress resources.

  • Your choice of over 40 Novartis-sponsored MS resources from international MS congresses in 2020 and 2021
  • View and download a diverse selection of oral presentations and ePosters
  • Get up close and personal with core MS data from the ASCLEPIOS and EXPAND Phase 3 clinical trials – start a data discussion with your patients and colleagues

AAN 2021

Conduct your own research on multiple sclerosis (MS) using our resources from the AAN, the Annual Meeting of the American Academy of Neurology.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

EAN 2021

Extend your learning of multiple sclerosis (MS) with the following selection of presentations from the EAN 2021.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

AAN 2020

Match the learning resources below from the AAN 2020 with your own educational objectives.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

EAN 2020

Broaden your understanding of multiple sclerosis (MS) – delve into our high-quality MS assets.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

ACTRIMS/ECTRIMS 2020

Explore Novartis-sponsored multiple sclerosis (MS) learnings from ACRTIMS/ECTRIMS 2020, the largest MS scientific conference in the world.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

References

  1. Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med. 2020;383(6):546–557.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: